2020 UAB Cardiovascular Institute Annual Report CVI Annual Report 2019-2020 6 | Page 32

RESEARCH
PREVENTIVE CARDIOLOGY
Section members are involved in major outcomes trials in clinical lipidology including ODYSSEY OUTCOMES,
STRENGTH, dal-GenE, CLEAR Outcomes, and ORION IV. They actively collaborate with the UAB School of Public
Health and multiple investigative groups outside the institution.
SELECTED PUBLICATIONS
• Kim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS, Guallar E, Zhao D, Michos ED. Association of
Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-
Analysis. Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004224. doi: 10.1161/CIRCOUTCOMES.117.004224. PMID:
29991644
• Shikany JM, Safford MM, Bryan J, Newby PK, Richman JS, Durant RW, Brown TM, Judd SE. Dietary Patterns and
Mediterranean Diet Score and Hazard of Recurrent Coronary Heart Disease Events and All-Cause Mortality in the
REGARDS Study. J American Heart Association 2018; May 8;7(10). pii: e008462. doi: 10.1161/JAHA.117.008462. PMID:
29739799
• Deo R, Safford MM, Khodneva YA, Jannat-Khah DP, Brown TM, Judd SE, McClellan WM, Rhodes JD, Shlipak MG,
Soliman EZ, Albert CM. Differences in Risk of Sudden Cardiac Death Between Blacks and Whites. J Am Coll Cardiol.
2018 Nov 13;72(20):2431-2439. doi: 10.1016/j.jacc.2018.08.2173.PMID: 30442286
• Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington
RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci
P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and Cardiovascular
Outcomes after Acute Coronary Syndrome. N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/
NEJMoa1801174. Epub 2018 Nov 7. PMID: 30403574
• Bittner V, Colantonio L, Dai Y, Woodward M, Mefford M, Rosenson R, Muntner P, Monda K, Kilgore M, Jaeger B,
Levitan E. Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After
Myocardial Infarction Among Medicare Beneficiaries. JAMA Cardiol. 2019 Jul 24. doi: 10.1001/jamacardio.2019.2481.
[Epub ahead of print] PMID: 31339519
OUTREACH TO THE COMMUNITY & THE UNDERSERVED
Born from an academic practice partnership (Maria Shirey, PhD, RN, and Connie White-Williams, PhD, RN)
between UAB Hospital and UAB School of Nursing, the Heart FailuRe Transitional Care Services for Adults
(HRTSA) clinic was funded by a federal Health Resources & Services Administration (HRSA) grant from 2014 to
2017 and has been sustained by UAB Hospital ever since.
The clinic is an interprofessional collaborative practice that brings many disciplines and areas together, such
as medicine (with collaborating physician Vera Bittner, MD); nursing (nurse practitioners, clinical nurse leaders,
registered nurses, and certified medical assistants); social work; behavioral health; pharmacy; the School of
Health Professions; and the School of Public Health. The clinic is the medical home for underserved adult patients
with heart failure who have no insurance, are under-insured, or lack a health care provider. It provides evidence-
based guidelines-directed medical care and utilizes a transitional care coordination model, which includes
rounding in the hospital, clinic visits, and a home visit. In addition, HRTSA uses a patient activation bundle that
addresses social determinants of health. Behavioral health is integrated into patient care.
Outcomes have been tracked since inception. Patients’ physical and mental health improves, patients become
more engaged in their self-care, and they report 96% satisfaction with the clinic. Annual inpatient days among
these underserved patients have been reduced from 1,294 pre-HRTSA to 266 in the most recent year.
30
UAB Cardiovascular Institute Annual Report
uabmedicine.org
31